Impact Factor Journals

ONDRUŠŠEK, R., B. KVOKACKOVA, K. KRYSTOFOVA, S. BRYCHTOVÁ, K. SOUCEK, J. BOUCHAL
Prognostic value and multifaceted roles of tetraspanin CD9 in cancer. Frontiers in Oncology. 2023, 13, 1140738, ISSN: 2234-943X, PMID: 37007105,  PDF.
IVASECHKO, I., A. LOZYNSKYI, J. SENKIV, P. ROSZCZENKO, Y. KOZAK, N. FINIUK, O. KLYUCHIVSKA, N. KASHCHAK, N. MANKO, Z. MASLYAK, D. LESYK, A. KARKHUT, S. POLOKVOVYCH, R. CZARNOMYSY, O. SZEWCZYK, A. KOZYTSKIY, O. KARPENKO, D. KHYLUK, A. GZELLA, K. BIELAWSKI, A. BIELAWSKA, P. DŽUBÁK, S. GURSKÁ, M. HAJDÚCH, R. STOIKA, R. LESYK
Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone). European Journal of Medicinal Chemistry. 2023, 252, 115304, ISSN: 0223-5234, PMID: 37001390,  PDF.
CHUDÁČEK, J., P. SPICKA, M. KOLÁŘ, M. STASEK, S. KOLCUN, D. KLOS, K. HRICOVÁ, P. MLYNÁRČIK, V. PUDOVÁ, O. KLEMENTOVA, R. HORACEK
Analysis of Bacterial Pathogens Causing Complicating HAP in Patients with Secondary Peritonitis. Antibiotics. 2023, 12(3), 527, ISSN: 2079-6382, PMID: 36978393,  PDF.
KOVALOVA, M., J. BARAKA, V. MIK, R. JORDA, M. LUO, H. SHAO, V. KRYŠTOF
A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022). Expert Opinion on Therapeutic Patents. 2023, 33(2), 67-87, ISSN: 1354-3776, PMID: 36975020,  PDF.
KOVALOVA, M., L. HAVLICEK, S. DJUKIC, J. SKERLOVA, M. PERINA, T. POSPÍŠIL, E. ŘEZNÍČKOVÁ, P. ŘEZÁČOVÁ, R. JORDA, V. KRYŠTOF
Characterization of new highly selective pyrazolo[4,3-d]pyrimidine inhibitor of CDK7. Biomedicine & Pharmacotherapy. 2023, 161, 114492, ISSN: 0753-3322, PMID: 36931035,  PDF.
BIELNIKOVA-KRYŠTOFOVA, H., O. MOTYKA, V. ŽIDLÍK, D. ZIAK, I. SZOTKOVSKA, J. ŠKARDA, J. VOVES, J. POMETLOVA, L. PLEVA, M. HAVLICEK, K. CABANOVA
Immunohistochemical evaluation of tissues following bone implant extraction from upper and lower limb. Histology and Histopathology. 2023, ISSN: 0213-3911, PMID: 36928509,
DOSTÁLOVÁ, H., R. JORDA, E. ŘEZNÍČKOVÁ, V. KRYŠTOF
Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines. Investigational New Drugs. 2023, 41(2), 210-219, ISSN: 0167-6997, PMID: 36913160,  PDF.
DE RESENDE, P., J. NISLER, J. VOLLER, A. KADLECOVA, S. GIBBONS
Antimicrobial and anthelmintic activities of aryl urea agents. Journal of Global Antimicrobial Resistance. 2023, 33, 114-119, ISSN: 2213-7165, PMID: 36906171,  PDF.
CARNA, M., J. NOVOTNÝ, N. DRAGISIC, H. SLAVÍK, K. SHEARDOVA, Y. GEDA, M. VYHNALEK, J. LACZO, J. HORT, Z. MAO, R. RISSMAN, M. HAJDÚCH, E. DAMMER, G. STOKIN
Missorting of Plasma miRNAs in Aging and Alzheimer's Disease. Journal of Neurochemistry. 2023, 165(2), 149-161, ISSN: 0022-2042, PMID: 36892419,
ANNADURAI, N., J. HRUBÝ, A. KUBÍČKOVÁ, L. MALINA, M. HAJDÚCH, V. DAS
Time- and dose-dependent seeding tendency of exogenous tau R2 and R3 aggregates in cells. Biochemical and Biophysical Research Communications. 2023, 653, 102-105, ISSN: 0006-291X, PMID: 36863211,  PDF.